The relation between serum level of amioterminal propeptide of type I procollagen and diastolic dysfunction in hypertensive patients without diabetes mellitus: A pilot study

Journal of Human Hypertension

Volumn 20, Issue 12, 2006, Pages 964-967

  Lin, Y H ^a   Chiu, Y W ^b   Shiau, Y C ^b   Yen, R F ^a   Tsai, I J ^a   Ho, Y L ^a   Huang, P J ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROCOLLAGEN TYPE 1 AMINOPROPEPTIDE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; PROTEIN PRECURSOR; TECHNETIUM 99M; THIAZIDE DIURETIC AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE FAILURE; HEART VENTRICULOGRAPHY; HUMAN; HYPERTENSION; M MODE ECHOCARDIOGRAPHY; MALE; PILOT STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RADIOIMMUNOASSAY; SYSTOLIC BLOOD PRESSURE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

AGED; BIOLOGICAL MARKERS; DIASTOLE; ENDOMYOCARDIAL FIBROSIS; FEMALE; HEART; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PILOT PROJECTS; PROCOLLAGEN; RADIONUCLIDE VENTRICULOGRAPHY; TECHNETIUM; VENTRICULAR FUNCTION;

EID: 33751241160     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002092     Document Type: Article

References (12)

1. Diez J, Lopez B, Gonzalez A, Querejeta R. Clinical aspects of hypertensive myocardial fibrosis. Curr Opin Cardiol 2001; 16: 328-335.
2. Lopez B, Gonzalez A, Varo N, Laviades C, Querejeta R, Diez J. Biochemical assessment of myocardial fibrosis in hypertensive heart disease. Hypertension 2001; 38: 1222-1226.
3. Lin YH, Shiau YC, Yen RF, Lin LC, Wu CC, Ho YL et al. The relation between myocardial cyclic variation of integrated backscatter and serum concentrations of procollagen propeptides in hypertensive patients. Ultrasound Med Biol 2004; 30: 885-891.
4. Lin YH, Ho YL, Wang TD, Liu CP, Kao HL, Chao CL et al. The relation of aminoterminal propeptide of type III procollagen and severity of coronary artery disease in patients without myocardial infarction or hibernation. Clin Clin Biochem (in press) DOI: 10.1016/ j.clinbiochem.2006.05.017.
5. Uusimaa P, Tokola H, Ylitalo A, Vuolteenaho O, Ruskoaho H, Risteli J et al. Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension. Int J Cardiol 2004; 97: 251-256.
6. Yamamoto K, Masuyama T, Sakata Y, Nishikawa N, Mano T, Yoshida J et al. Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart. Cardiovasc Res 2002; 55: 76-82.
7. Cuocolo A, Sax FL, Brush JE, Maron BJ, Bacharach SL, Bonow RO. Left ventricular hypertrophy and impaired diastolic filling in essential hypertension. Diastolic mechanisms for systolic dysfunction during exercise. Circulation 1990; 81: 978-986.
8. Granier P, Esquerre JP, Tredez P, Conte D, Bernadet P, Galinier F. between M-mode markers of left ventricular hypertrophy and radionuclide angiographic indices of left ventricular diastolic function in mild to moderate hypertension. J Hypertens Suppl 1989; 7: S100-S101.
9. Caruana M, Al-Khawaja I, Lahiri A, Lewis J, Raftery EB. measurements of diastolic function for assessing early left ventricular abnormalities in the hypertensive patient. Br Heart J 1988; 59: 218-226.
10. Nii T, Nakashima Y, Ikeda M, Arakawa K. Diastolic filling abnormality modified by left ventricular asynchrony in essential hypertension. Acta Cardiol 1991; 46: 471-477.
11. Sugihara N, Genda A, Shimizu M, Suematsu T, Kita Y, Minamoto M et al. Diastolic dysfunction and its relation to myocardial fibrosis in essential hypertension. J Cardiol 1988; 18: 353-361.
12. Tayebjee MH, Lim HS, Nadar S, MacFadyen RJ, Lip GY. Tissue inhibitor of metalloproteinse-1 is a marker of diastolic dysfunction using tissue doppler in patients with type 2 diabetes and hypertension. Eur J Clin Invest 2005; 35: 8-12.